Related Experiment Video
Updated: Jan 12, 2026

06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
33.7K
Assessing Alzheimer's disease knowledge in the Syrian population using the ADKS: A cross-sectional study
Mouhammed Sleiay1, Taha Yassen Almohammad2, Bilal Sleiay1
1Faculty of Medicine, Hama University, Hama, Syria.
Medicine
|November 5, 2025
Summary
Public knowledge of Alzheimer disease (AD) is moderate in Syria, with significant gaps in understanding caregiving and preventive drugs. Targeted educational campaigns are crucial to improve awareness and support for individuals with AD.
Area of Science:
- Neuroscience
- Public Health
- Gerontology
Background:
- Alzheimer disease (AD) is a growing global challenge, disproportionately affecting women.
- Limited public knowledge about AD causes and progression hinders effective management.
- Understanding AD knowledge in diverse populations is crucial for public health initiatives.
Purpose of the Study:
- To assess Alzheimer disease (AD) knowledge among Syrian adults using the Alzheimer Disease Knowledge Scale (ADKS).
- To identify demographic factors associated with AD knowledge levels in the Syrian population.
Main Methods:
- A cross-sectional study was conducted with 685 Syrian adults (≥18 years) using the Arabic version of the ADKS.
- Data were collected electronically and analyzed using descriptive statistics, t tests, ANOVA, and correlation analyses.
- Ethical approval and informed consent were obtained prior to data collection.
Main Results:
- Overall moderate AD knowledge was observed (mean score: 18.79/30), with higher scores linked to increased education, healthcare information access, and family history of AD.
- Participants demonstrated higher knowledge in AD's life impact and treatment domains.
- Significant knowledge gaps were identified in understanding preventive drugs (20.4% correct) and caregiving strategies (11.1% correct).
Conclusions:
- This study highlights moderate public awareness of AD in Syria but reveals critical knowledge deficits in key areas.
- Targeted educational interventions focusing on caregiving and preventive strategies are essential.
- Healthcare professional-led outreach is vital to enhance AD awareness, facilitate early diagnosis, and support caregivers.
Related Concept Videos
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
801
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
801
Dementia
508
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
508

